ATE205221T1 - Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms - Google Patents
Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndromsInfo
- Publication number
- ATE205221T1 ATE205221T1 AT96920118T AT96920118T ATE205221T1 AT E205221 T1 ATE205221 T1 AT E205221T1 AT 96920118 T AT96920118 T AT 96920118T AT 96920118 T AT96920118 T AT 96920118T AT E205221 T1 ATE205221 T1 AT E205221T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- detecting
- immune deficiency
- deficiency syndrome
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000011580 syndromic disease Diseases 0.000 title 1
- 206010001513 AIDS related complex Diseases 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000001541 thymus gland Anatomy 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43188395A | 1995-05-01 | 1995-05-01 | |
| US48554895A | 1995-06-07 | 1995-06-07 | |
| US64193696A | 1996-05-01 | 1996-05-01 | |
| PCT/US1996/006079 WO1996034886A1 (en) | 1995-05-01 | 1996-05-01 | Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205221T1 true ATE205221T1 (de) | 2001-09-15 |
Family
ID=27411755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96920118T ATE205221T1 (de) | 1995-05-01 | 1996-05-01 | Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz- syndroms |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP0826003B1 (de) |
| CN (1) | CN1221568C (de) |
| AT (1) | ATE205221T1 (de) |
| BG (1) | BG64056B1 (de) |
| CA (1) | CA2220347C (de) |
| DE (1) | DE69615015T2 (de) |
| DK (1) | DK0826003T3 (de) |
| EA (1) | EA001100B1 (de) |
| ES (1) | ES2163028T3 (de) |
| IL (1) | IL118103A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008057479A1 (de) | 2008-11-14 | 2010-05-20 | Bernhard, Stefan, Dr. | Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse |
| CN116466071A (zh) * | 2020-12-28 | 2023-07-21 | 重庆生命知源科技有限公司 | 上样缓冲液的应用及一种微量蛋白免疫印迹检测方法 |
| CN119746205B (zh) * | 2024-12-25 | 2025-09-30 | 深圳市浩然盈科通讯科技有限公司 | 一种智能输液控制方法、系统、存储介质及程序产品 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4415553A (en) * | 1973-08-06 | 1983-11-15 | Dso "Pharmachim" | Compositions, processes for their preparation and method for treatment of neoplasms |
| EP0149468B1 (de) * | 1984-01-12 | 1990-10-31 | SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH | Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke |
| AU2800389A (en) * | 1987-12-02 | 1989-07-05 | Regents Of The University Of California, The | Aids-related anti-t-cell antibody test |
| GB9209874D0 (en) * | 1992-05-07 | 1992-06-24 | Ml Lab Plc | Pharmaceutical compositions |
-
1996
- 1996-05-01 EP EP96920118A patent/EP0826003B1/de not_active Expired - Lifetime
- 1996-05-01 DK DK96920118T patent/DK0826003T3/da active
- 1996-05-01 AT AT96920118T patent/ATE205221T1/de not_active IP Right Cessation
- 1996-05-01 CA CA002220347A patent/CA2220347C/en not_active Expired - Fee Related
- 1996-05-01 EP EP00125954A patent/EP1104770A3/de not_active Withdrawn
- 1996-05-01 EA EA199700353A patent/EA001100B1/ru not_active IP Right Cessation
- 1996-05-01 ES ES96920118T patent/ES2163028T3/es not_active Expired - Lifetime
- 1996-05-01 IL IL11810396A patent/IL118103A/xx not_active IP Right Cessation
- 1996-05-01 CN CNB961952032A patent/CN1221568C/zh not_active Expired - Fee Related
- 1996-05-01 DE DE69615015T patent/DE69615015T2/de not_active Expired - Fee Related
-
1997
- 1997-11-28 BG BG102083A patent/BG64056B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0826003B1 (de) | 2001-09-05 |
| EP0826003A1 (de) | 1998-03-04 |
| DK0826003T3 (da) | 2001-11-26 |
| BG64056B1 (bg) | 2003-11-28 |
| HK1009457A1 (en) | 1999-06-04 |
| IL118103A (en) | 2000-02-29 |
| CA2220347C (en) | 2003-03-18 |
| BG102083A (en) | 1998-10-30 |
| EA199700353A1 (ru) | 1998-04-30 |
| CA2220347A1 (en) | 1996-11-07 |
| DE69615015T2 (de) | 2002-06-27 |
| EP1104770A2 (de) | 2001-06-06 |
| CN1221568C (zh) | 2005-10-05 |
| ES2163028T3 (es) | 2002-01-16 |
| DE69615015D1 (de) | 2001-10-11 |
| EA001100B1 (ru) | 2000-10-30 |
| CN1189839A (zh) | 1998-08-05 |
| EP1104770A3 (de) | 2001-06-27 |
| IL118103A0 (en) | 1997-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nara et al. | Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies | |
| EA199800638A1 (ru) | Смесь рекомбинантных векторов вируса коровьей оспы в качестве полиоболоченных вирусных вакцин против вируса иммунного дефицита человека | |
| CY1106207T1 (el) | Αντιιικα παραγωγα νουκλεοζιτων | |
| ATE418562T1 (de) | Ctl epitope des epstein-barr virus | |
| EP0675904A4 (de) | Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch. | |
| GR1000489B (el) | Αλληλουχιες dna,μορια ανασυνδιασμενου dna και μεθοδοι για την παραγωγη διαλυτων τ4 πρωτεινων. | |
| IL118625A0 (en) | Anti HBV antibodies | |
| WO2002068654A3 (es) | Poxvirus recombinantes para proteinas quimericas del virus de la inmunodeficiencia humana | |
| GR3022248T3 (en) | Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses | |
| CA2218561A1 (en) | Compounds and methods of use to treat infectious diseases | |
| DE69615015D1 (de) | Zusammensetzungen und verfahren zur detektion und behandlung des erworbenen immun-defizienz-syndroms | |
| WO2005111079A3 (en) | Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 | |
| DE69026506D1 (de) | Biologisches präparat und seine verwendung | |
| BR9608837A (pt) | "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano" | |
| Steimer et al. | HIV-1 neutralization directed to epitopes other than linear V3 determinants | |
| ATE284709T1 (de) | Virale chimären aus caev und hiv-1 genetischen elementen | |
| IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
| KR100871455B1 (ko) | Ｈｉｖ 바이러스에 대한 천연 항체 | |
| EP0491888A4 (en) | Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| FR2678835B1 (fr) | Composition a base de buis pour le traitement de l'infection par le vih (virus de l'immunodefiscience humaine). | |
| EP0328390A2 (de) | Peptidbehandlung von hartnäckigen Infektionskrankheiten | |
| WO2002026253A1 (en) | A vaccine for acids and its preparation and use | |
| Koprowski et al. | Anti-idiotype vaccines against viral infections | |
| DK0470989T3 (da) | Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |